Request that the FDA determine whether NDA 214652, Atropine Sulfate Injection, 0.4 mg/mL held by Accord Healthcare Inc has been voluntarily withdrawn or withheld from sale for reasons of safety or efficacy
🏛 Food and Drug Administration (FDA)FDA-2026-P-7043
Documents
3
Total comments
0
all analyzed
Comment status
Open
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Jun 25, 2026No comment period
- Supporting & Related Material· Jun 25, 2026